< 1 minute read
Sep. 18, 2021

Compound 46: An Oral Brain-Penetrant PDE2A Phosphodiesterase Inhibitor

"compound 46"

oral sel. PDE2A phosphodiesterase inhibitor for cognition, target engagement in brain from HTS, SBDD, and FEP claculations J. Med. Chem., Oct. 26, 2020 Janssen Pharmaceutica NV, Beerse, BE

Drug Hunter Team

“compound 46” (Janssen oral selective brain-penetrant PDE2A phosphodiesterase inhibitor)



Other molecules you may be interested in